MedMesh.i
Checkpoint
PubMed
Racine
Checkpoint
PubMed
Exploration
Accueil
Racine
Racine

Serveur d'exploration Tocilizumab - Checkpoint (PubMed)

Index « MedMesh.i » - entrée « Withholding Treatment »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Wiskott-Aldrich Syndrome Protein Family < Withholding Treatment < Women  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 18.
Ident.Authors (with country if any)Title
000351 (2019) Sabine Adler [Allemagne] ; Stephan Reichenbach ; Andrea Gloor ; Daniel Yerly [Suisse] ; Jennifer L. Cullmann [Suisse] ; Peter M. VilligerRisk of relapse after discontinuation of tocilizumab therapy in giant cell arteritis.
000361 (2019) Shunsuke Mori [Japon] ; Tamami Yoshitama [Japon] ; Yasuyo Abe [Japon] ; Toshihiko Hidaka [Japon] ; Naoyuki Hirakata [Japon] ; Kiyoshi Aoyagi [Japon] ; Yukitaka Ueki [Japon]Retention of tocilizumab with and without methotrexate during maintenance therapy for rheumatoid arthritis: the ACTRA-RI cohort study.
000366 (2019) Carlotta Nannini [Italie] ; Laura Niccoli [Italie] ; Stelvio Sestini [Italie] ; Iashar Laghai [Italie] ; Angela Coppola [Italie] ; Fabrizio Cantini [Oman]Remission maintenance after tocilizumab dose-tapering and interruption in patients with giant cell arteritis: an open-label, 18-month, prospective, pilot study.
000505 (2019) Kim Lauper [Suisse] ; Denis Mongin [Suisse] ; Deshire Alpizar-Rodriguez [Suisse] ; Catalin Codreanu [Italie] ; Florenzo Iannone [Italie] ; Eirik K. Kristianslund [Norvège] ; Tore K. Kvien [Norvège] ; Karel Pavelka [République tchèque] ; Manuel Pombo-Suarez [Espagne] ; Maria J. Santos ; Cem Gabay [Suisse] ; Axel Finckh [Suisse] ; Delphine S. Courvoisier [Suisse]Drug retention of biological DMARD in rheumatoid arthritis patients: the role of baseline characteristics and disease evolution.
000680 (2018) Joel M. Kremer [États-Unis] ; William Rigby [États-Unis] ; Nora G. Singer [États-Unis] ; Christine Birchwood [États-Unis] ; Darcy Gill [États-Unis] ; William Reiss [États-Unis] ; Jinglan Pei [États-Unis] ; Margaret Michalska [États-Unis]Sustained Response Following Discontinuation of Methotrexate in Patients With Rheumatoid Arthritis Treated With Subcutaneous Tocilizumab: Results From a Randomized, Controlled Trial.
000A87 (2017) Takayuki Katsuyama [Japon] ; Ken-Ei Sada [Japon] ; Minglu Yan [Japon] ; Sonia Zeggar [Japon] ; Sumie Hiramatsu [Japon] ; Yoshia Miyawaki [Japon] ; Keiji Ohashi [Japon] ; Michiko Morishita [Japon] ; Haruki Watanabe [Japon] ; Eri Katsuyama [Japon] ; Mariko Takano-Narazaki [Japon] ; Noriko Toyota-Tatebe [Japon] ; Katsue Sunahori-Watanabe [Japon] ; Tomoko Kawabata [Japon] ; Kohei Miyake [Japon] ; Toru Kiguchi ; Jun Wada [Japon]Prognostic factors of methotrexate-associated lymphoproliferative disorders associated with rheumatoid arthritis and plausible application of biological agents.
000C59 (2016) Masakatsu Saitoh ; Kazuhiko Matsushita[Prevention of surgical site infection for orthopaedic surgery in rheumatoid arthritis].
000D70 (2016) Alejandro Souto [Oman] ; José Ram N Maneiro ; Juan J. G Mez-Reino [Espagne]Rate of discontinuation and drug survival of biologic therapies in rheumatoid arthritis: a systematic review and meta-analysis of drug registries and health care databases.
000E37 (2016) Coline Faivre [France] ; Axel Patrice Villani [France] ; François Aubin [France] ; Dan Lipsker [France] ; Martine Bottaro [France] ; Jean-David Cohen [France] ; François Durupt [France] ; Géraldine Jeudy [France] ; Emilie Sbidian [France] ; Eric Toussirot [France] ; Valérie Badot [Belgique] ; Sébastien Barbarot [France] ; Sébastien Debarbieux [France] ; Emmanuel Delaporte [France] ; Guetty Goegebeur [France] ; Jacques Morel [France] ; Aude Nassif [France] ; Gérard Duru [France] ; Denis Jullien [France]Hidradenitis suppurativa (HS): An unrecognized paradoxical effect of biologic agents (BA) used in chronic inflammatory diseases.
001115 (2015) T Martijn Kuijper [Pays-Bas] ; Femke B G. Lamers-Karnebeek ; Johannes W G. Jacobs ; Johanna M W. Hazes ; Jolanda J. LuimeFlare Rate in Patients with Rheumatoid Arthritis in Low Disease Activity or Remission When Tapering or Stopping Synthetic or Biologic DMARD: A Systematic Review.
001139 (2015) Kathleen Morrisroe [Oman] ; Melinda Wong [Australie]Drug-induced hypereosinophilia related to tocilizumab therapy for rheumatoid arthritis.
001142 (2015) Helena Forsblad-D'Elia [Suède] ; Karin Bengtsson [Suède] ; Lars Erik Kristensen [Suède] ; Lennart T H. Jacobsson [Suède]Drug adherence, response and predictors thereof for tocilizumab in patients with rheumatoid arthritis: results from the Swedish biologics register.
001439 (2013) L. Sailler [France] ; G. Pugnet ; B. Bienvenu[Treatment of giant cell arteritis].
001567 (2013) Said Younis [Israël] ; Itzhak Rosner ; Doron Rimar ; Nina Boulman ; Michael Rozenbaum ; Majed Odeh ; Gleb SlobodinInterleukin 6 blockade-associated weight gain with abdominal enlargement in a patient with rheumatoid arthritis.
001707 (2012) Javier Rueda-Gotor [Espagne] ; Miguel A. González-Gay ; Ricardo Blanco Alonso ; Carmen Gonzalez-Vela ; Cristina Lopez-Obregon ; Marcos A. González-L PezSuccessful effect of tocilizumab in anti-TNF-α-induced palmoplantar pustulosis in rheumatoid arthritis.
001781 (2012) Ryoko Sakai [Japon] ; Michi Tanaka ; Toshihiro Nanki ; Kaori Watanabe ; Hayato Yamazaki ; Ryuji Koike ; Hayato Nagasawa ; Koichi Amano ; Kazuyoshi Saito ; Yoshiya Tanaka ; Satoshi Ito ; Takayuki Sumida ; Atsushi Ihata ; Yoshiaki Ishigatsubo ; Tatsuya Atsumi ; Takao Koike ; Atsuo Nakajima ; Naoto Tamura ; Takao Fujii ; Hiroaki Dobashi ; Shigeto Tohma ; Takahiko Sugihara ; Yukitaka Ueki ; Akira Hashiramoto ; Atsushi Kawakami ; Noboru Hagino ; Nobuyuki Miyasaka ; Masayoshi HarigaiDrug retention rates and relevant risk factors for drug discontinuation due to adverse events in rheumatoid arthritis patients receiving anticytokine therapy with different target molecules.
001943 (2011) Ryo Hiroshima [Japon] ; Kosei Kawakami ; Takuji Iwamoto ; Asami Tokita ; Koichiro Yano ; Yu Sakuma ; Katsunori Ikari ; Shigeki MomoharaAnalysis of C-reactive protein levels and febrile tendency after joint surgery in rheumatoid arthritis patients treated with a perioperative 4-week interruption of tocilizumab.
001C57 (????) Daniela Santos-Faria ; José Tavares-Costa ; M Nica Eusébio ; Joana Leite Silva ; Joana Ramos Rodrigues ; Joana Sousa-Neves ; Ana Catarina Duarte ; Carina Lopes ; Ana Valido ; Joana Dinis ; João Freitas ; Mariana Santiago ; Raquel Ferreira ; Sara Ganhão ; Luís Miranda ; Daniela Peixoto ; Filipa Teixeira ; Sérgio Alcino ; Carmo Afonso ; Maria José SantosTocilizumab and rituximab have similar effectiveness and are both superior to a second tumour necrosis factor inhibitor in rheumatoid arthritis patients who discontinued a first TNF inhibitor.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/PubMed/Checkpoint

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/MedMesh.i -k "Withholding Treatment" 

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/MedMesh.i  \
                -Sk "Withholding Treatment" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    PubMed
   |étape=   Checkpoint
   |type=    indexItem
   |index=    MedMesh.i
   |clé=    Withholding Treatment
}}
Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021